Oklahoma vs Texas Cannabis Laws

Oklahoma's medical cannabis market is unlike any other in the United States. State Question 788, approved by voters in June 2018, created what is widely considered the most permissive medical cannabis program in the country. The law imposes minimal qualifying condition requirements (essentially any condition a physician deems appropriate), no license caps, and relatively low barriers to entry. The result has been explosive growth — and equally dramatic oversupply.

At its peak, Oklahoma issued over 12,000 cannabis business licenses, a staggering number for a state of 4 million residents. Approximately 10% of the state's adult population holds a medical marijuana patient card. This open approach generated over $1.5 billion in peak annual sales but has also led to severe price compression, widespread business failures, and regulatory challenges. A recreational legalization ballot measure failed in March 2023 with only 38% support.

No major multi-state operators have established a significant presence in Oklahoma, largely because the open license structure and rock-bottom wholesale prices make it difficult to generate attractive returns. The market serves as a case study in the consequences of minimal barriers to entry in cannabis licensing. Despite its challenges, Oklahoma remains one of the highest-revenue medical cannabis markets in the nation.

Texas has one of the most restrictive medical cannabis programs in the country. The Texas Compassionate Use Act, signed in 2015, created the Compassionate Use Program (CUP), initially limited to patients with intractable epilepsy and restricted to low-THC cannabis products. HB 1535, passed in 2021, expanded the program to include additional qualifying conditions such as cancer, PTSD, and certain neurodegenerative diseases, and raised the THC cap from 0.5% to 1%. Despite these expansions, the program remains far more limited than standard medical cannabis programs in other states.

The Texas market structure is extraordinarily restrictive. Only 3 vertically integrated dispensing organizations are licensed to operate statewide, serving a population of approximately 30 million people. This creates significant access challenges for patients, as the limited number of dispensary locations cannot adequately serve the state's vast geography. Products are limited to low-THC cannabis preparations, and the 1% THC cap means patients cannot access the full-potency products available in most medical states.

Despite being the second most populous state, Texas generates modest cannabis revenue estimated at roughly $50 million annually from its CUP program. The extremely limited license structure, low THC cap, and restricted qualifying conditions severely constrain the market. No major MSOs currently operate in Texas, as the 3 existing licenses are held by local operators. If Texas were to significantly expand its medical program or legalize recreational cannabis, it would instantly become one of the largest cannabis markets in the world. Market analysts estimate a fully legalized Texas market could generate $3-5 billion in annual sales, making it a closely watched state for potential reform.